FDA AND CE APPROVED
Ventripoint Diagnostics' VMS+ system has received U.S. Food and Drug Administration (FDA) 510(k) clearance [21]. The most recent, VMS+ 4.0 system, received 510(k) clearance in February 2025, which is used to analyze heart chamber volumes and function (ejection fraction) in 3D using 2D ultrasound [22].
Key Details Regarding FDA Status:
- 510(k) Cleared: The VMS+ system has received 510(k) clearance, indicating it is substantially equivalent to legally marketed devices for measuring heart volume and function [24].
- Latest Version: The VMS+ 4.0 was cleared in February 2025, featuring AI-assisted, magnet-free technology suitable for patients with cardiac pacemakers [22].
- Clinical Use: The technology is designed to produce MRI-quality measurements of all four chambers of the heart, with applications in both pediatric and adult cardiac care.
- Vendor Neutral: The VMS+ system connects to standard ultrasound machines from various manufacturers.

No comments:
Post a Comment